Theratechnologies (TSE:TH) Stock Price Passes Below 200 Day Moving Average of $1.83

Theratechnologies Inc. (TSE:TH)’s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$1.83 and traded as low as C$1.61. Theratechnologies shares last traded at C$1.68, with a volume of 8,325 shares.

Theratechnologies Stock Performance

The company has a 50 day simple moving average of C$1.80 and a 200-day simple moving average of C$1.83. The company has a debt-to-equity ratio of 562.07, a current ratio of 1.10 and a quick ratio of 0.64. The stock has a market cap of C$74.95 million, a P/E ratio of -9.06, a price-to-earnings-growth ratio of -8.50 and a beta of 1.74.

Theratechnologies (TSE:TH) last announced its quarterly earnings data on Wednesday, July 10th. The company reported C$0.03 earnings per share for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. The firm had revenue of C$30.00 million during the quarter. On average, equities analysts expect that Theratechnologies Inc. will post 0.0302262 earnings per share for the current fiscal year.

Theratechnologies Company Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.